Peytant wins FDA de novo nod for covered stent system
October 22, 2024
Peytant Solutions announced today that the FDA granted marketing authorization for its AMStent tracheobronchial covered stent system.
Peytant Solutions announced today that the FDA granted marketing authorization for its AMStent tracheobronchial covered stent system.
Siemens Healthineers says a new FDA clearance will advance the care of people at risk of heart attacks in the United States.
Mucocort AB has been granted a patent in China for its innovative product/technology, which has previously been approved under the European Patent System (EPC).
Boston Scientific (NYSE: BSX)+
announced today that it received FDA approval for its navigation-enabled Farawave Nav ablation catheter and clearance for new Faraview software.
Cook Medical announced that it launched its NestVT vitrification device for in-vitro fertilization (IVF) in the U.S.
Novocure announced on Tuesday that the FDA treated its Optune Lua wearable device for treating metastatic non-small cell lung cancer.
Johnson & Johnson MedTech (NYSE: JNJ)+
today announced the first completed commercial case with its Varipulse platform in Canada.
Mira has launched Mira Hormone Monitor: Menopause Transitions Kit to help women aged 35 and older track their hormones to spot early signs of perimenopause and manage them effectively.
With heart attacks, every second counts. A new blood test diagnoses them in minutes rather than hours and could be adapted as a tool for first responders and people at home.
Go to the doctor to provide a blood sample, and you’re typically faced with a needle and syringe, and hours or even days of waiting to get results back from a lab. CU Boulder researchers hope to change that with a new handheld, sound-based diagnostic system able to deliver precise results in an hour with a mere finger prick of blood.